Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2025)

Historic Net Income towards Common Stockholders for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$19.5 million.

  • Outset Medical's Net Income towards Common Stockholders rose 2397.61% to -$19.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$81.7 million, marking a year-over-year increase of 3619.66%. This contributed to the annual value of -$81.7 million for FY2025, which is 3619.66% up from last year.
  • Per Outset Medical's latest filing, its Net Income towards Common Stockholders stood at -$19.5 million for Q4 2025, which was up 2397.61% from -$17.8 million recorded in Q3 2025.
  • Outset Medical's Net Income towards Common Stockholders' 5-year high stood at -$17.8 million during Q3 2025, with a 5-year trough of -$46.2 million in Q3 2023.
  • For the 5-year period, Outset Medical's Net Income towards Common Stockholders averaged around -$33.9 million, with its median value being -$35.7 million (2022).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 82158.14% in 2021, then surged by 4618.62% in 2025.
  • Quarter analysis of 5 years shows Outset Medical's Net Income towards Common Stockholders stood at -$41.2 million in 2021, then fell by 0.51% to -$41.4 million in 2022, then rose by 6.86% to -$38.6 million in 2023, then surged by 33.58% to -$25.6 million in 2024, then rose by 23.98% to -$19.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$19.5 million for Q4 2025, versus -$17.8 million for Q3 2025 and -$18.5 million for Q2 2025.